LEOVYLAS Trademark

Trademark Overview


On Wednesday, October 28, 2020, a trademark application was filed for LEOVYLAS with the United States Patent and Trademark Office. The USPTO has given the LEOVYLAS trademark a serial number of 79300608. The federal status of this trademark filing is REGISTERED as of Tuesday, August 3, 2021. This trademark is owned by Glaxo Group Limited. The LEOVYLAS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and medicinal preparations and substances for the treatment of oncological, respiratory, viral and immuno-inflammatory diseases and disorders, none of the aforementioned for the treatment of skin and skin disorders; vaccines
leovylas

General Information


Serial Number79300608
Word MarkLEOVYLAS
Filing DateWednesday, October 28, 2020
Status700 - REGISTERED
Status DateTuesday, August 3, 2021
Registration Number6436582
Registration DateTuesday, August 3, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 18, 2021

Trademark Statements


Goods and ServicesPharmaceutical and medicinal preparations and substances for the treatment of oncological, respiratory, viral and immuno-inflammatory diseases and disorders, none of the aforementioned for the treatment of skin and skin disorders; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 11, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Friday, July 28, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Sunday, October 3, 2021NOTIFICATION PROCESSED BY IB
Wednesday, September 15, 2021FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, September 15, 2021FINAL DISPOSITION PROCESSED
Thursday, September 2, 2021GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, August 3, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, July 20, 2021LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Saturday, July 10, 2021LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, May 18, 2021PUBLISHED FOR OPPOSITION
Monday, May 17, 2021NOTIFICATION PROCESSED BY IB
Wednesday, April 28, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 28, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 28, 2021NOTICE OF PUBLICATION
Wednesday, April 14, 2021LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Monday, April 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 30, 2021ASSIGNED TO EXAMINER
Friday, March 26, 2021LIMITATION FROM THE IB EXAMINED AND ENTERED
Saturday, March 20, 2021LIMITATION OF GOODS RECEIVED FROM IB
Saturday, March 13, 2021LIMITATION OF GOODS RECEIVED FROM IB
Friday, January 15, 2021APPLICATION FILING RECEIPT MAILED
Monday, January 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 7, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 24, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB